Gene: OPRM1

4988
LMOR|M-OR-1|MOP|MOR|MOR1|OPRM
OD receptor mu 1
protein-coding
6q25.2
Ensembl:ENSG00000112038 MIM:600018 Vega:OTTHUMG00000015870 UniprotKB:P35372
NG_021208.2
PubMed
CD|OD|ND|AD
164   
NA (AD)  NA (ND)   (Frontal_Cortex)
2.432e-1 (AD)  1.835e-1 (ND)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg22719623chr6:154360732OPRM1Promoter4.874e-4Alcohol use disorders26763658
cg17256711chr6:154331078OPRM11.000e-9Smoking27651444

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
ERVW-10.725
ERVH48-10.718
TMEM2470.711
NYAP20.704
TAS2R300.685
PPIAP100.683
PRAMEF170.679
OR56A40.679
C9orf1310.677
PRDM140.675

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
ASB4-0.348
PLA2G5-0.336
ENDOU-0.331
C16orf74-0.323
COPZ2-0.321
TPPP2-0.312
RARRES2-0.308
AQP6-0.286
GCSH-0.283
APOM-0.282

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00193TramadolSmall Molecule27203-92-5Approved|InvestigationalTarget
DB00295MorphineSmall Molecule57-27-2Approved|InvestigationalTarget
DB00318CodeineSmall Molecule76-57-3Approved|IllicitTarget
DB00321AmitriptylineSmall Molecule50-48-6ApprovedTarget
DB00327HydromorphoneSmall Molecule466-99-9Approved|IllicitTarget
DB00333MethadoneSmall Molecule76-99-3ApprovedTarget
DB00454PethidineSmall Molecule57-42-1ApprovedTarget
DB00497OxycodoneSmall Molecule76-42-6Approved|Illicit|InvestigationalTarget
DB00504LevallorphanSmall Molecule152-02-3ApprovedTarget
DB00514DextromethorphanSmall Molecule125-71-3ApprovedTarget
DB00611ButorphanolSmall Molecule42408-82-2Approved|IllicitTarget
DB00647DextropropoxypheneSmall Molecule469-62-5Approved|Illicit|Investigational|WithdrawnTarget
DB00652PentazocineSmall Molecule359-83-1ApprovedTarget
DB00704NaltrexoneSmall Molecule16590-41-3Approved|InvestigationalTarget
DB00708SufentanilSmall Molecule56030-54-7Approved|InvestigationalTarget
DB00802AlfentanilSmall Molecule71195-58-9Approved|IllicitTarget
DB00813FentanylSmall Molecule437-38-7Approved|Illicit|InvestigationalTarget
DB00836LoperamideSmall Molecule53179-11-6ApprovedTarget
DB00844NalbuphineSmall Molecule20594-83-6ApprovedTarget
DB00854LevorphanolSmall Molecule77-07-6ApprovedTarget
DB00899RemifentanilSmall Molecule132875-61-7ApprovedTarget
DB00904OndansetronSmall Molecule99614-02-5ApprovedTarget
DB00913AnileridineSmall Molecule144-14-9Approved|IllicitTarget
DB00921BuprenorphineSmall Molecule52485-79-7Approved|Illicit|InvestigationalTarget
DB00956HydrocodoneSmall Molecule125-29-1Approved|IllicitTarget
DB01081DiphenoxylateSmall Molecule915-30-0Approved|IllicitTarget
DB01183NaloxoneSmall Molecule465-65-6ApprovedTarget
DB01192OxymorphoneSmall Molecule76-41-5Approved|InvestigationalTarget
DB01209DezocineSmall Molecule53648-55-8Approved|InvestigationalTarget
DB01221KetamineSmall Molecule6740-88-1ApprovedTarget
DB01227Levomethadyl AcetateSmall Molecule1477-40-3Approved|InvestigationalTarget
DB01433Methadyl AcetateSmall Molecule509-74-0Approved|IllicitTarget
DB014393-MethylthiofentanylSmall Molecule86052-04-2Experimental|IllicitTarget
DB01444DimethylthiambuteneSmall Molecule524-84-5Experimental|IllicitTarget
DB01452HeroinSmall Molecule561-27-3Approved|Illicit|InvestigationalTarget
DB01466EthylmorphineSmall Molecule76-58-4Approved|IllicitTarget
DB01497EtorphineSmall Molecule14521-96-1IllicitTarget
DB01535CarfentanilSmall Molecule59708-52-0Illicit|InvestigationalTarget
DB01548DiprenorphineSmall Molecule14357-78-9IllicitTarget
DB01565DihydromorphineSmall Molecule509-60-4Experimental|IllicitTarget
DB015713-MethylfentanylSmall Molecule42045-86-3IllicitTarget
DB05046V1003Small Molecule-InvestigationalTarget
DB05492Epicept NP-1Small Molecule-InvestigationalTarget
DB05509LI-301Small Molecule-InvestigationalTarget
DB06204TapentadolSmall Molecule175591-23-8ApprovedTarget
DB06230NalmefeneSmall Molecule55096-26-9Approved|Investigational|WithdrawnTarget
DB06274AlvimopanSmall Molecule156053-89-3Approved|InvestigationalTarget
DB06738KetobemidoneSmall Molecule469-79-4Approved|InvestigationalTarget
DB06800MethylnaltrexoneSmall Molecule916055-93-1ApprovedTarget
DB09049NaloxegolSmall Molecule854601-70-0ApprovedTarget
DB09061CannabidiolSmall Molecule13956-29-1Approved|InvestigationalTarget
DB09089TrimebutineSmall Molecule39133-31-8ApprovedTarget
DB09209PholcodineSmall Molecule509-67-1Approved|IllicitTarget
DB09272EluxadolineSmall Molecule864821-90-9Approved|InvestigationalTarget
DB09396Propoxyphene napsylateSmall MoleculeApprovedTarget
DB11130OpiumSmall Molecule8008-60-4Approved|IllicitTarget
DB11691NaldemedineSmall Molecule916072-89-4Approved|InvestigationalTarget
ID Drug Name Action PubMed
C0245661,1,1-trichloroethane"1,1,1-trichloroethane results in decreased expression of OPRM1 mRNA"25270620
C50085114-benzyloxy-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one"14-benzyloxy-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"15857143
C08194914-methoxymetopon14-methoxymetopon binds to and results in increased activity of OPRM1 protein19800397
C08194914-methoxymetopon"14-methoxymetopon inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
C08194914-methoxymetopon14-methoxymetopon binds to and results in increased activity of OPRM1 protein19800397
C08194914-methoxymetopon"14-methoxymetopon inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"15857143|1980039
C08194914-methoxymetopon14-methoxymetopon binds to and results in increased activity of OPRM1 protein21235243
C54734914-O-methyloxymorphone14-O-methyloxymorphone binds to and results in increased activity of OPRM1 protein19800397
C54734914-O-methyloxymorphone"14-O-methyloxymorphone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
C54734914-O-methyloxymorphone14-O-methyloxymorphone binds to and results in increased activity of OPRM1 protein19800397
C54734914-O-methyloxymorphone"14-O-methyloxymorphone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"15857143|1980039
C47856514-phenylpropoxymetopon14-phenylpropoxymetopon binds to OPRM1 protein21235243
C5076341,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane"1,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane binds to and results in increased activity of OPRM1 protein"17142049
C5076341,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane"1,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane metabolite binds to and results in increased activity of OPRM1 protein"17142049
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OPRM1 mRNA"25510870
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OPRM1 mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OPRM1 mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OPRM1 mRNA"25510870
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OPRM1 mRNA"25510870
C0174872-mercaptoacetateOPRM1 exon affects the susceptibility to 2-mercaptoacetate10802031
C5076353,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone"3,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone binds to and results in increased activity of OPRM1 protein"17142049
C5076353,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone"3,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone metabolite binds to and results in increased activity of OPRM1 protein"17142049
C586842((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine binds to OPRM1 protein23300227
C586842((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine"((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine inhibits the reaction [[OPRM1 protein co-treated with Enkephalin, Ala(2)-MePhe(4)-Gly(5)-] results in increased activity of ARRB2 protein]"23300227
C586842((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine binds to OPRM1 protein23300227
C586842((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine[OPRM1 protein co-treated with ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine] results in increased activity of ARRB2 protein23300227
C586842((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine binds to OPRM1 protein23300227
C586842((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine binds to and results in increased activity of OPRM1 protein24063433|2755670
C0005950156,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine"6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine results in increased expression of OPRM1 mRNA"28073004
C0238336 alpha-naloxol6 alpha-naloxol binds to and results in decreased activity of OPRM1 protein11413242
C0104106 beta-hydroxynaltrexone6 beta-hydroxynaltrexone binds to and results in decreased activity of OPRM1 protein11413242
C0238346 beta-naloxol6 beta-naloxol binds to and results in decreased activity of OPRM1 protein11413242
C0773587-benzylidenenaltrexone[7-benzylidenenaltrexone binds to and results in decreased activity of OPRM1 protein] which affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
C0773587-benzylidenenaltrexone[7-benzylidenenaltrexone binds to and results in decreased activity of OPRM1 protein] which results in increased expression of Cyclic AMP11413242
C0773587-benzylidenenaltrexone7-benzylidenenaltrexone binds to and results in decreased activity of OPRM1 protein11413242
C4826787-hydroxymitragynine"7-hydroxymitragynine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"27192616
C4826787-hydroxymitragynine7-hydroxymitragynine binds to and results in increased activity of OPRM1 protein27192616
C4826787-hydroxymitragynine7-hydroxymitragynine binds to OPRM1 protein27192616
C5029829-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester"9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester binds to and results in increased activity of OPRM1 protein"27556704
D000157AconitineOPRM1 protein affects the susceptibility to Aconitine16995444
D000242Cyclic AMP[7-benzylidenenaltrexone binds to and results in decreased activity of OPRM1 protein] which results in increased expression of Cyclic AMP11413242
D000242Cyclic AMP[chlornaltrexamine binds to and results in decreased activity of OPRM1 protein] which results in increased expression of Cyclic AMP11413242
D000242Cyclic AMP[clocinnamox binds to and results in decreased activity of OPRM1 protein] which results in increased expression of Cyclic AMP11413242
D000242Cyclic AMP[nalmefene binds to and results in decreased activity of OPRM1 protein] which results in increased expression of Cyclic AMP11413242
D000242Cyclic AMP[[Naloxone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] results in increased expression of Cyclic AMP11413242
D000242Cyclic AMP[[Naltrexone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] results in increased expression of Cyclic AMP11413242
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of OPRM1 gene27153756
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine inhibits the reaction [[OPRM1 protein co-treated with Enkephalin, Ala(2)-MePhe(4)-Gly(5)-] results in increased activity of ARRB2 protein]"23300227
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"7-hydroxymitragynine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"27192616
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Buprenorphine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"21866885
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein"21866885|2195833
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased activity of OPRM1 protein"26476280
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased phosphorylation of OPRM1 protein"23300227
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"mitragynine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"27192616
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"27192616
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"[OPRM1 protein co-treated with Enkephalin, Ala(2)-MePhe(4)-Gly(5)-] results in increased activity of ARRB2 protein"23300227|2719261
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"14-methoxymetopon inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"14-O-methyloxymorphone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"ADORA2A protein affects the reaction [[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein] which results in increased activity of Guanosine 5'-O-(3-Thiotriphosphate)]"14756803
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein"27192616
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein"14756803|1689360
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein] which results in increased activity of Guanosine 5'-O-(3-Thiotriphosphate)"14756803
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"mitragynine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"27192616
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"mitragynine pseudoindoxyl inhibits the reaction [[OPRM1 protein co-treated with Enkephalin, Ala(2)-MePhe(4)-Gly(5)-] results in increased activity of ARRB2 protein]"27556704
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Morphine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"OPRM1 gene mutant form inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"16893609|1689360
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"[OPRM1 protein co-treated with Enkephalin, Ala(2)-MePhe(4)-Gly(5)-] results in increased activity of ARRB2 protein"27556704
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Oxymorphone affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"14-benzyloxy-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"15857143
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"14-methoxymetopon inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"15857143|1980039
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"14-O-methyloxymorphone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"15857143|1980039
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Cadmium inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Cannabidiol promotes the reaction [Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]]"16489449
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Copper inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"CTAP octapeptide inhibits the reaction [[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein] which results in increased susceptibility to Cocaine]"19279569
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Dronabinol promotes the reaction [Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]]"16489449
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein"1528399|16489449
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein] which results in increased susceptibility to Cocaine"19279569
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein"10891866|1199125
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Magnesium promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Manganese promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Mercury inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Morphine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"[Naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"8987795
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"16489449
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"OPRM1 results in increased susceptibility to Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"8987795
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Oxymorphone affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Zinc inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Zinc inhibits the reaction [Magnesium promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]]"2162496
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Zinc inhibits the reaction [Manganese promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]]"2162496
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]]"12031848
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]]"12031848
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]"12031848
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]]"12031848
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein"10078993|1053412
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein"24345467
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased activity of [OPRD1 protein binds to OPRM1 protein]"23818586
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased activity of OPRM1 protein"24345467
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"24345467
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"Morphine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"24345467
D020875Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"tyrosyl-tetrahydroisoquinolinecarbonyl-psi(methylamino)phenylalanyl-phenylalanine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased activity of [OPRD1 protein binds to OPRM1 protein]]"23818586
D015760AlfentanilAlfentanil binds to and results in increased activity of OPRM1 protein11240593
D000535Aluminum[APP protein modified form binds to Aluminum] which results in decreased expression of OPRM1 mRNA21298039
C419502alvimopanalvimopan binds to and results in decreased activity of OPRM1 protein18313920
C419502alvimopanalvimopan binds to OPRM1 protein17340127
C419502alvimopanalvimopan metabolite binds to OPRM1 protein17340127
D005680gamma-Aminobutyric AcidOPRM1 protein mutant form results in decreased secretion of gamma-Aminobutyric Acid20203187
D000643Ammonium ChlorideAmmonium Chloride affects the expression of OPRM1 mRNA16483693
D003913DextroamphetamineDextroamphetamine affects the expression of OPRM1 mRNA12629526
C032739aroclor 1221aroclor 1221 inhibits the reaction [aroclor 1221 results in decreased expression of OPRM1 mRNA]26620572
C032739aroclor 1221aroclor 1221 results in decreased expression of OPRM1 mRNA26620572
C032739aroclor 1221aroclor 1221 results in increased expression of OPRM1 mRNA26620572
D001464Barium"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]]"12031848
D001464Barium"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]"12031848
D001464Barium"omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]]"12031848
D001464BariumOPRM1 protein affects the reaction [Potassium results in increased transport of Barium]12031848
D001464BariumOPRM1 protein affects the transport of Barium12031848
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of OPRM1 mRNA19428949
C024524beta-funaltrexamine[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Nicotine15778877
C024524beta-funaltrexamine"[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of 3,4-Dihydroxyphenylacetic Acid]"8884884
C024524beta-funaltrexamine[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of Homovanillic Acid]8884884
C024524beta-funaltrexamine[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Morphine8884884
C024524beta-funaltrexaminebeta-funaltrexamine binds to and results in decreased activity of OPRM1 protein12937158|1577887
C035438beta-naltrexaminebeta-naltrexamine binds to and results in decreased activity of OPRM1 protein11413242
C006780bisphenol Abisphenol A results in decreased expression of OPRM1 mRNA25181051
D002047BuprenorphineBuprenorphine binds to and affects the activity of OPRM1 protein21866885
D002047BuprenorphineBuprenorphine binds to and results in increased activity of OPRM1 protein16010532
D002047Buprenorphine"Buprenorphine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"21866885
D002047BuprenorphineBuprenorphine binds to OPRM1 protein7562497
D002047BuprenorphineBuprenorphine binds to and affects the activity of OPRM1 protein10862807
D002047BuprenorphineBuprenorphine binds to and results in increased activity of OPRM1 protein15966752|1640165
D002047BuprenorphineBuprenorphine binds to OPRM1 protein15897523
D0200011-Butanol[1-Butanol inhibits the reaction [PLD2 protein results in increased chemical synthesis of Phosphatidic Acids]] affects the reaction [PENK protein binds to and results in increased activity of OPRM1 protein]14720217
D002077ButorphanolButorphanol affects the activity of OPRM1 protein17909753
D002077ButorphanolButorphanol affects the activity of OPRM1 protein17909753
D002077ButorphanolButorphanol affects the activity of OPRM1 protein17909753
D002077ButorphanolButorphanol binds to and results in increased activity of OPRM1 protein11561074
D002104Cadmium"Cadmium inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D002118Calcium[Tetradecanoylphorbol Acetate co-treated with Calcium] inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
C058819calphostin Ccalphostin C inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCA protein]]18652891
C058819calphostin Ccalphostin C inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
C061465calphostin complexcalphostin complex inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein binds to RAF1 protein]]21235400
D002185Cannabidiol"Cannabidiol promotes the reaction [Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]]"16489449
D002211CapsaicinCapsaicin inhibits the reaction [carfentanil binds to OPRM1 protein]12406535
C017114carfentanilCapsaicin inhibits the reaction [carfentanil binds to OPRM1 protein]12406535
C017114carfentanilCocaine affects the reaction [carfentanil binds to OPRM1 protein]15953495
C017114carfentanilcarfentanil binds to and results in increased activity of OPRM1 protein12406535|1876291
C017114carfentanilcarfentanil binds to OPRM1 protein15953495
D002395Catecholamines"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]]"12031848
D002395CatecholaminesOPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]12031848
C017120chlornaltrexamine[chlornaltrexamine binds to and results in decreased activity of OPRM1 protein] which affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
C017120chlornaltrexamine[chlornaltrexamine binds to and results in decreased activity of OPRM1 protein] which results in increased expression of Cyclic AMP11413242
C017120chlornaltrexaminechlornaltrexamine binds to and results in decreased activity of OPRM1 protein11413242
C076806clocinnamox[clocinnamox binds to and results in decreased activity of OPRM1 protein] which affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
C076806clocinnamox[clocinnamox binds to and results in decreased activity of OPRM1 protein] which results in increased expression of Cyclic AMP11413242
C076806clocinnamoxclocinnamox binds to and results in decreased activity of OPRM1 protein11413242
D003000Clonidine[Naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Clonidine8987795
D003000ClonidineOPRM1 results in increased susceptibility to Clonidine8987795
C007095cobaltiprotoporphyrincobaltiprotoporphyrin affects the expression of OPRM123358127
D003042CocaineCocaine results in increased expression of OPRM1 mRNA23226419
D003042CocaineCocaine affects the reaction [carfentanil binds to OPRM1 protein]15953495
D003042CocaineOPRM1 gene SNP results in increased susceptibility to Cocaine12815747
D003042CocaineCocaine results in decreased expression of OPRM1 mRNA10081923
D003042CocaineCocaine results in increased activity of OPRM1 protein17532787
D003042CocaineOPRM1 gene mutant form results in decreased susceptibility to Cocaine16893609
D003042CocaineOPRM1 mutant form results in decreased susceptibility to Cocaine15664692
D003042CocaineOPRM1 protein affects the susceptibility to Cocaine10803207
D003042CocainePDYN protein affects the reaction [Cocaine results in increased activity of OPRM1 protein]17532787
D003042CocaineCocaine affects the expression of OPRM1 mRNA15950784|1899054
D003042CocaineCocaine affects the expression of OPRM1 protein10891866
D003042CocaineCocaine results in decreased expression of OPRM1 mRNA12128154
D003042Cocaine[CTAP octapeptide binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [POMC protein results in increased susceptibility to Cocaine]19279569
D003042Cocaine"CTAP octapeptide inhibits the reaction [[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein] which results in increased susceptibility to Cocaine]"19279569
D003042Cocaine"[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein] which results in increased susceptibility to Cocaine"19279569
D003061CodeineCodeine binds to OPRM1 protein7562497
C009862connective tissue-activating peptideconnective tissue-activating peptide binds to and results in decreased activity of OPRM1 protein16954126
D003300CopperCopper deficiency results in increased expression of OPRM1 mRNA26033743
D003300Copper"Copper inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
C529311CTAP octapeptideCTAP octapeptide binds to and results in decreased activity of OPRM1 protein22258905
C529311CTAP octapeptide[CTAP octapeptide binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [POMC protein results in increased susceptibility to Cocaine]19279569
C529311CTAP octapeptide[CTAP octapeptide binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Methamphetamine20298714
C529311CTAP octapeptide"CTAP octapeptide inhibits the reaction [[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein] which results in increased susceptibility to Cocaine]"19279569
C529311CTAP octapeptideCTAP octapeptide binds to and results in decreased activity of OPRM1 protein17687547|1927956
D003496CyclazocineCyclazocine binds to and results in decreased activity of OPRM1 protein9788768
D003513CycloheximideCycloheximide inhibits the reaction [Dronabinol results in increased expression of OPRM1 mRNA]16434616
C084603cyclorphancyclorphan binds to OPRM1 protein21351746
C084603cyclorphancyclorphan analog binds to and results in increased activity of OPRM1 protein10812979
C084603cyclorphancyclorphan binds to and results in decreased activity of OPRM1 protein10812979
C583602CYM51010CYM51010 promotes the reaction [[OPRD1 protein binds to OPRM1 protein] which binds to Guanosine 5'-O-(3-Thiotriphosphate)]23818586
C583602CYM51010CYM51010 results in increased activity of OPRM1 protein23818586
C583602CYM51010Naltrexone inhibits the reaction [CYM51010 promotes the reaction [[OPRD1 protein binds to OPRM1 protein] which binds to Guanosine 5'-O-(3-Thiotriphosphate)]]23818586
C058450cyprodime[cyprodime binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Phenytoin7870991
C058450cyprodimecyprodime binds to and results in decreased activity of OPRM1 protein11520128|7870991
C014347decitabinedecitabine results in increased expression of OPRM1 mRNA22262103
C014347decitabinedecitabine affects the methylation of OPRM1 promoter17452465
C014347decitabine[decitabine affects the methylation of OPRM1 promoter] which affects the expression of OPRM1 mRNA17452465|1745246
D013759DronabinolCycloheximide inhibits the reaction [Dronabinol results in increased expression of OPRM1 mRNA]16434616
D013759DronabinolDronabinol results in increased expression of OPRM1 mRNA16434616
D013759DronabinolGATA3 affects the reaction [Dronabinol results in increased expression of OPRM1 mRNA]16434616
D013759DronabinolIL4 protein mutant form inhibits the reaction [Dronabinol results in increased expression of OPRM1 mRNA]16434616
D013759Dronabinoliodopravadoline inhibits the reaction [Dronabinol results in increased expression of OPRM1 mRNA]16434616
D013759DronabinolSTAT5A affects the reaction [Dronabinol results in increased expression of OPRM1 mRNA]16434616
D013759DronabinolSTAT6 affects the reaction [Dronabinol results in increased expression of OPRM1 mRNA]16434616
D013759DronabinolOPRM1 affects the susceptibility to Dronabinol11826143
D013759DronabinolDronabinol promotes the reaction [Guanosine Triphosphate binds to OPRM1 protein]16823391
D013759Dronabinol"Dronabinol promotes the reaction [Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]]"16489449
D013759DronabinolDronabinol results in increased activity of OPRM1 protein10101241
C060209deltorphin II, Ala(2)-"deltorphin II, Ala(2)- results in increased activity of [OPRD1 protein binds to OPRM1 protein]"23818586
C060209deltorphin II, Ala(2)-"phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide promotes the reaction [deltorphin II, Ala(2)- results in increased activity of [OPRD1 protein binds to OPRM1 protein]]"23818586
C030058dermorphindermorphin binds to and results in increased activity of OPRM1 protein21870874
C044130dextrallorphandextrallorphan binds to OPRM1 protein7562497
C044130dextrallorphan[dextrallorphan binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
C044130dextrallorphan[dextrallorphan binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D003917DextrorphanDextrorphan binds to OPRM1 protein7562497
D003917Dextrorphan[Dextrorphan binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D003917Dextrorphan[Dextrorphan binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D004041Dietary FatsDietary Fats results in increased expression of OPRM1 mRNA18721800
D019422Dietary SucroseDietary Sucrose results in increased expression of OPRM1 mRNA26033743
D0151023,4-Dihydroxyphenylacetic Acid"[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of 3,4-Dihydroxyphenylacetic Acid]"8884884
D004147DioxinsDioxins affects the expression of OPRM1 mRNA20463971
D016291Dizocilpine MaleateDizocilpine Maleate inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]]18652891
D016291Dizocilpine MaleateDizocilpine Maleate inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
C569763Dmt-NMe-Ala-Aba-Gly-NH2Dmt-NMe-Ala-Aba-Gly-NH2 binds to OPRM1 protein21978284
C569763Dmt-NMe-Ala-Aba-Gly-NH2[Dmt-NMe-Ala-Aba-Gly-NH2 binds to OPRM1 protein] which results in increased phosphorylation of MAPK1 protein21978284
C569763Dmt-NMe-Ala-Aba-Gly-NH2[Dmt-NMe-Ala-Aba-Gly-NH2 binds to OPRM1 protein] which results in increased phosphorylation of MAPK3 protein21978284
D007980Levodopa"[Levodopa co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased activity of OPRM1 protein"15802193
D004399DynorphinsDynorphins results in increased activity of OPRM1 protein26476280
D004399DynorphinsDynorphins analog binds to OPRM1 protein11270320
C105293endomorphin 1endomorphin 1 binds to and results in increased activity of OPRM1 protein17142049
C105293endomorphin 1endomorphin 1 metabolite binds to and results in decreased activity of OPRM1 protein17142049
C105293endomorphin 1endomorphin 1 affects the activity of OPRM1 protein11726782
C105293endomorphin 1[naloxonazine binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to endomorphin 111726782
C105293endomorphin 1endomorphin 1 binds to and results in increased activity of OPRM1 protein10988119
C105294endomorphin 2endomorphin 2 binds to and results in increased activity of OPRM1 protein17142049
C105294endomorphin 2endomorphin 2 metabolite binds to and results in decreased activity of OPRM1 protein17142049
C105294endomorphin 2[OPRM1 protein co-treated with endomorphin 2] results in increased activity of ARRB2 protein27556704
C105294endomorphin 2endomorphin 2 binds to and results in increased activity of OPRM1 protein10988119
D004743Enkephalin, Leucine"Enkephalin, Leucine results in increased activity of OPRM1 protein"26476280
D004837EpinephrineOPRM1 protein affects the susceptibility to Epinephrine16995444
D004967EstrogensESR1 affects the reaction [Estrogens affects the localization of OPRM1 protein]12605406
D004967EstrogensEstrogens affects the localization of OPRM1 protein12605406
D000431EthanolOPRM1 gene SNP results in increased susceptibility to Ethanol12815747
D000431EthanolOPRM1 protein affects the susceptibility to Ethanol17339526
D000431EthanolOPRM1 protein affects the susceptibility to Ethanol10803207
D005038EthylnitrosoureaEthylnitrosourea results in increased mutagenesis of OPRM1 gene16495775
C084835etonitazeneetonitazene results in increased phosphorylation of OPRM1 protein21957251
D005283FentanylFentanyl results in increased phosphorylation of OPRM1 protein23300227
D005283FentanylFentanyl results in increased phosphorylation of OPRM1 protein17240843|2195725
D005283FentanylFentanyl binds to and results in increased activity of OPRM1 protein16099308|1611303
D005283FentanylFentanyl binds to OPRM1 protein8267194
C061872FK 409FK 409 promotes the reaction [OPRM1 protein binds to PRKCG protein]18652891|2123540
C061872FK 409FK 409 promotes the reaction [OPRM1 protein binds to RAF1 protein]21235400
C061872FK 409FK 409 promotes the reaction [OPRM1 protein binds to RGS17 protein]18652891
C061872FK 409"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [FK 409 promotes the reaction [OPRM1 protein binds to PRKCG protein]]"21235400
C061872FK 409"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [FK 409 promotes the reaction [OPRM1 protein binds to RAF1 protein]]"21235400
D005473FluoxetineFluoxetine inhibits the reaction [Methamphetamine results in decreased expression of OPRM1 mRNA]21886566
D005473FluoxetineFluoxetine inhibits the reaction [Methamphetamine results in decreased expression of OPRM1 protein]21886566
D005473FluoxetineFluoxetine results in increased expression of OPRM1 protein16484055
C039281furanfuran results in decreased expression of OPRM1 mRNA26194646
D016244Guanosine 5'-O-(3-Thiotriphosphate)[7-benzylidenenaltrexone binds to and results in decreased activity of OPRM1 protein] which affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D016244Guanosine 5'-O-(3-Thiotriphosphate)[chlornaltrexamine binds to and results in decreased activity of OPRM1 protein] which affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D016244Guanosine 5'-O-(3-Thiotriphosphate)[clocinnamox binds to and results in decreased activity of OPRM1 protein] which affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D016244Guanosine 5'-O-(3-Thiotriphosphate)"ADORA2A protein affects the reaction [[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein] which results in increased activity of Guanosine 5'-O-(3-Thiotriphosphate)]"14756803
D016244Guanosine 5'-O-(3-Thiotriphosphate)"[Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein] which results in increased activity of Guanosine 5'-O-(3-Thiotriphosphate)"14756803
D016244Guanosine 5'-O-(3-Thiotriphosphate)CYM51010 promotes the reaction [[OPRD1 protein binds to OPRM1 protein] which binds to Guanosine 5'-O-(3-Thiotriphosphate)]23818586
D016244Guanosine 5'-O-(3-Thiotriphosphate)[nalmefene binds to and results in decreased activity of OPRM1 protein] which affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D016244Guanosine 5'-O-(3-Thiotriphosphate)[[Naloxone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D016244Guanosine 5'-O-(3-Thiotriphosphate)[[Naltrexone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D016244Guanosine 5'-O-(3-Thiotriphosphate)Naltrexone inhibits the reaction [CYM51010 promotes the reaction [[OPRD1 protein binds to OPRM1 protein] which binds to Guanosine 5'-O-(3-Thiotriphosphate)]]23818586
D016244Guanosine 5'-O-(3-Thiotriphosphate)[OPRD1 protein binds to OPRM1 protein] which binds to Guanosine 5'-O-(3-Thiotriphosphate)23818586
D006160Guanosine TriphosphateDronabinol promotes the reaction [Guanosine Triphosphate binds to OPRM1 protein]16823391
D006160Guanosine TriphosphateGuanosine Triphosphate binds to OPRM1 protein16823391
C000611307GUM1 compoundGUM1 compound results in increased activity of OPRM1 protein26476280
D006220HaloperidolOPRM1 protein inhibits the reaction [Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]]20184921
D003932HeroinHeroin binds to and results in increased activity of OPRM1 protein18597954
D006719Homovanillic Acid[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of Homovanillic Acid]8884884
D017313FenretinideFenretinide results in decreased expression of OPRM1 mRNA28973697
D012701Serotonin[dextrallorphan binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D012701Serotonin[Dextromethorphan binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D012701Serotonin[Dextropropoxyphene binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D012701Serotonin[Dextrorphan binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D012701Serotonin[Levallorphan binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D012701Serotonin[Levorphanol binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D012701Serotonin[Methadone binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D012701Serotonin[Methadyl Acetate binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D012701Serotonin[Tramadol binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D006853HydrocodoneHydrocodone binds to OPRM1 protein7562497
D006853HydrocodoneHydrocodone binds to and results in increased activity of OPRM1 protein15893155
C094023iodopravadolineiodopravadoline inhibits the reaction [Dronabinol results in increased expression of OPRM1 mRNA]16434616
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of OPRM1 mRNA25613284
D007531IsoflurophateOPRM1 affects the susceptibility to Isoflurophate15378609|1580040
C402944JHW 015JHW 015 results in increased expression of OPRM1 mRNA16434616
C008261lead acetatelead acetate results in decreased expression of OPRM1 mRNA21891863
D007977LevallorphanLevallorphan binds to OPRM1 protein7562497
D007977Levallorphan[Levallorphan binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D007977Levallorphan[Levallorphan binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D007981LevorphanolLevorphanol binds to OPRM1 protein7562497
D007981Levorphanol[Levorphanol binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D007981Levorphanol[Levorphanol binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of OPRM1 mRNA18977430
D018021Lithium ChlorideLithium Chloride results in decreased expression of OPRM1 protein17919468
D008139LoperamideLoperamide binds to and results in increased activity of OPRM1 protein20604828
D008274Magnesium"Magnesium promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D008274Magnesium"Zinc inhibits the reaction [Magnesium promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]]"2162496
D008345Manganese"Manganese promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D008345Manganese"Zinc inhibits the reaction [Manganese promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]]"2162496
D008614MeperidineMeperidine binds to OPRM1 protein8267194
D008628Mercury"Mercury inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D008691MethadoneMethadone binds to OPRM1 protein7562497
D008691Methadone[Methadone binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D008691Methadone[Methadone binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D008691MethadoneMethadone binds to and results in increased activity of OPRM1 protein10215673|1859795
D008692Methadyl AcetateMethadyl Acetate binds to OPRM1 protein7562497
D008692Methadyl Acetate[Methadyl Acetate binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D008692Methadyl Acetate[Methadyl Acetate binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D008692Methadyl AcetateMethadyl Acetate binds to and results in increased activity of OPRM1 protein10215673|1086280
D008694MethamphetamineOPRM1 gene SNP results in increased susceptibility to Methamphetamine16402083
D008694MethamphetamineFluoxetine inhibits the reaction [Methamphetamine results in decreased expression of OPRM1 mRNA]21886566
D008694MethamphetamineFluoxetine inhibits the reaction [Methamphetamine results in decreased expression of OPRM1 protein]21886566
D008694MethamphetamineMethamphetamine results in decreased expression of OPRM1 mRNA21886566
D008694MethamphetamineMethamphetamine results in decreased expression of OPRM1 protein21886566
D008694MethamphetamineOPRM1 protein affects the susceptibility to [Methamphetamine results in decreased expression of TH mRNA]22329540
D008694MethamphetamineOPRM1 protein affects the susceptibility to [Methamphetamine results in decreased expression of TH protein]22329540
D008694MethamphetamineOPRM1 protein inhibits the reaction [Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]]20184921
D008694Methamphetamine[CTAP octapeptide binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Methamphetamine20298714
D008694MethamphetamineMethamphetamine results in increased expression of OPRM1 mRNA15644446
D003915DextromethorphanDextromethorphan binds to OPRM1 protein7562497
D003915Dextromethorphan[Dextromethorphan binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D003915Dextromethorphan[Dextromethorphan binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D008727MethotrexateMethotrexate results in increased expression of OPRM1 mRNA24449571
C533093methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate"methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate binds to and results in increased activity of OPRM1 protein"24345467
C587452methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate"methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"24345467
C587452methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate"methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate results in increased activity of OPRM1 protein"24345467
C445068methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate"methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in decreased activity of OPRM1 protein"28790194
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of OPRM1 mRNA23103053
C032257methylnaltrexonemethylnaltrexone binds to OPRM1 protein17340127
C032257methylnaltrexonemethylnaltrexone binds to and results in decreased activity of OPRM1 protein18183536
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"[Levodopa co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased activity of OPRM1 protein"15802193
C001801mitragynine"mitragynine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"27192616
C001801mitragyninemitragynine binds to and results in increased activity of OPRM1 protein27192616
C001801mitragyninemitragynine inhibits the reaction [Tretinoin results in increased expression of OPRM1 mRNA]23608241
C001801mitragyninemitragynine binds to OPRM1 protein27192616
C001801mitragynine"mitragynine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"27192616
C121049mitragynine pseudoindoxylmitragynine pseudoindoxyl binds to and results in increased activity of OPRM1 protein27556704
C121049mitragynine pseudoindoxyl"mitragynine pseudoindoxyl inhibits the reaction [[OPRM1 protein co-treated with Enkephalin, Ala(2)-MePhe(4)-Gly(5)-] results in increased activity of ARRB2 protein]"27556704
C121049mitragynine pseudoindoxylOPRM1 exon mutant form results in decreased susceptibility to mitragynine pseudoindoxyl27556704
C028889morphiceptinmorphiceptin binds to and results in increased activity of OPRM1 protein8383026
C028889morphiceptinmorphiceptin binds to and results in increased activity of OPRM1 protein2557556|3015659|
D009020Morphine[COMT gene SNP co-treated with OPRM1 gene SNP] affects the susceptibility to Morphine21127283
D009020MorphineMorphine affects the activity of OPRM1 protein11106302
D009020MorphineMorphine binds to and results in increased activity of OPRM1 protein17656655
D009020MorphineMorphine inhibits the reaction [Tretinoin results in increased expression of OPRM1 mRNA]23608241
D009020MorphineMorphine results in increased activity of OPRM1 protein26476280
D009020MorphineMorphine results in increased phosphorylation of OPRM1 protein23300227
D009020Morphine[[Naloxone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] results in increased expression of Cyclic AMP11413242
D009020MorphineNaloxone inhibits the reaction [Morphine inhibits the reaction [Tretinoin results in increased expression of OPRM1 mRNA]]23608241
D009020Morphine[[Naltrexone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] results in increased expression of Cyclic AMP11413242
D009020MorphineOPRM1 affects the susceptibility to Morphine23748253
D009020MorphineOPRM1 exon SNP results in decreased susceptibility to Morphine15504181
D009020MorphineOPRM1 protein affects the reaction [Morphine results in decreased secretion of FGF2 protein]20564181
D009020MorphineOPRM1 protein affects the susceptibility to Morphine22258905
D009020Morphine[OPRM1 protein co-treated with Morphine] results in increased activity of ARRB2 protein23300227
D009020MorphineDizocilpine Maleate inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]]18652891
D009020MorphineDizocilpine Maleate inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D009020MorphineHINT1 affects the reaction [Morphine promotes the reaction [OPRM1 protein binds to MAPK1 protein]]21235400
D009020MorphineHINT1 affects the reaction [Morphine promotes the reaction [OPRM1 protein binds to MAPK3 protein]]21235400
D009020MorphineHINT1 affects the reaction [Morphine promotes the reaction [OPRM1 protein binds to RAF1 protein]]21235400
D009020MorphineHINT1 gene mutant form inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCA protein]]18652891
D009020MorphineHINT1 gene mutant form inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCB protein]]18652891
D009020MorphineHINT1 gene mutant form inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D009020MorphineHINT1 gene mutant form inhibits the reaction [Morphine results in increased phosphorylation of OPRM1 protein]18652891
D009020Morphine"Morphine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D009020MorphineMorphine binds to and affects the activity of OPRM1 protein19800397
D009020MorphineMorphine binds to and results in increased activity of OPRM1 protein11272841|1260540
D009020MorphineMorphine promotes the reaction [OPRM1 protein binds to MAPK1 protein]21235400
D009020MorphineMorphine promotes the reaction [OPRM1 protein binds to MAPK3 protein]21235400
D009020MorphineMorphine promotes the reaction [OPRM1 protein binds to PRKCA protein]18652891
D009020MorphineMorphine promotes the reaction [OPRM1 protein binds to PRKCB protein]18652891
D009020MorphineMorphine promotes the reaction [OPRM1 protein binds to PRKCG protein]18652891|2123540
D009020MorphineMorphine promotes the reaction [OPRM1 protein binds to RAF1 protein]21235400
D009020MorphineMorphine results in decreased expression of OPRM1 mRNA26877219
D009020MorphineMorphine results in increased activity of OPRM1 protein17996026
D009020Morphine[Morphine results in increased activity of OPRM1 protein] which results in increased phosphorylation of GRIN1 protein17996026
D009020MorphineMorphine results in increased expression of OPRM1 protein21957251
D009020MorphineMorphine results in increased phosphorylation of OPRM1 protein18652891|2195725
D009020MorphineNaloxone inhibits the reaction [Morphine results in increased phosphorylation of OPRM1 protein]21957251
D009020MorphineOPRM1 affects the activity of Morphine12213227
D009020MorphineOPRM1 gene mutant form inhibits the reaction [Morphine results in decreased expression of IFNG]11590188
D009020MorphineOPRM1 gene mutant form inhibits the reaction [Morphine results in decreased expression of IL2]11590188
D009020MorphineOPRM1 protein affects the susceptibility to Morphine10803207
D009020Morphine[phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Morphine17996026
D009020MorphineTetradecanoylphorbol Acetate inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D009020Morphinevalyl-prolyl-aspartyl-prolyl-arginine inhibits the reaction [Morphine results in increased activity of OPRM1 protein]11272841
D009020Morphine[Zymosan co-treated with Morphine] results in increased expression of OPRM1 mRNA15979727
D009020Morphine"[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of 3,4-Dihydroxyphenylacetic Acid]"8884884
D009020Morphine[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of Homovanillic Acid]8884884
D009020Morphine[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Morphine8884884
D009020Morphine"Morphine affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D009020MorphineMorphine binds to and affects the activity of OPRM1 protein19800397
D009020MorphineMorphine binds to OPRM1 protein7562497
D009020Morphine[naloxonazine binds to and results in decreased activity of OPRM1 protein] which affects the susceptibility to Morphine9264103
D009020Morphine[naloxonazine binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Morphine8884884
D009020Morphine[Morphine affects the activity of OPRM1 protein] which results in decreased susceptibility to OXT protein9151298
D009020MorphineMorphine binds to and results in increased activity of OPRM1 protein10319781|1646444
D009020MorphineMorphine binds to OPRM1 protein12350293
D009020Morphine"Morphine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"24345467
D009020Morphine[[Naloxone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D009020Morphine[[Naltrexone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
C440388N-(3-iodoprop-(2)-enyl)N-(3-iodoprop-(2)-enyl) binds to OPRM1 protein11591513
C048599N(6)-cyclopentyladenosine[Naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to N(6)-cyclopentyladenosine8987795
D009266NalbuphineNalbuphine binds to and results in decreased activity of OPRM1 protein15810761
D009266NalbuphineNalbuphine binds to and results in increased activity of OPRM1 protein16517095
C038981nalmefenenalmefene binds to and results in decreased activity of OPRM1 protein9862779
C038981nalmefene[nalmefene binds to and results in decreased activity of OPRM1 protein] which results in increased expression of Cyclic AMP11413242
C038981nalmefenenalmefene binds to and results in decreased activity of OPRM1 protein11413242
C038981nalmefene[nalmefene binds to and results in decreased activity of OPRM1 protein] which affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
C034643naloxonazinenaloxonazine binds to and results in decreased activity of OPRM1 protein11726782
C034643naloxonazine[naloxonazine binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to endomorphin 111726782
C034643naloxonazine[naloxonazine binds to and results in decreased activity of OPRM1 protein] which affects the susceptibility to Morphine9264103
C034643naloxonazine[naloxonazine binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Morphine8884884
C034643naloxonazinenaloxonazine binds to and results in decreased activity of OPRM1 protein10802031|8884884
D009270Naloxone[[Naloxone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] results in increased expression of Cyclic AMP11413242
D009270Naloxone"Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"27192616
D009270NaloxoneNaloxone inhibits the reaction [Morphine inhibits the reaction [Tretinoin results in increased expression of OPRM1 mRNA]]23608241
D009270NaloxoneNaloxone inhibits the reaction [Morphine results in increased phosphorylation of OPRM1 protein]21957251
D009270Naloxone"Cannabidiol promotes the reaction [Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]]"16489449
D009270Naloxone"Dronabinol promotes the reaction [Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]]"16489449
D009270NaloxoneNaloxone binds to and results in decreased activity of OPRM1 protein1528399|1654493|
D009270Naloxone[Naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Clonidine8987795
D009270Naloxone"[Naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Enkephalin, Ala(2)-MePhe(4)-Gly(5)-"8987795
D009270Naloxone[Naloxone binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to N(6)-cyclopentyladenosine8987795
D009270NaloxoneNaloxone binds to OPRM1 protein7562497
D009270Naloxone"Naloxone inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to and results in increased activity of OPRM1 protein]"16489449
D009270NaloxoneNaloxone binds to and results in decreased activity of OPRM1 protein10988119|1141324
D009270Naloxone[[Naloxone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D009270NaloxoneNaloxone binds to OPRM1 protein12350293|1893114
D009270NaloxoneNaloxone results in decreased activity of OPRM1 protein10070497
D009271Naltrexone[[Naltrexone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] results in increased expression of Cyclic AMP11413242
D009271NaltrexoneOPRM1 affects the susceptibility to Naltrexone18250251
D009271NaltrexoneNaltrexone binds to OPRM1 protein7562497
D009271NaltrexoneNaltrexone binds to and results in decreased activity of OPRM1 protein11413242|1640165
D009271Naltrexone[[Naltrexone binds to and results in decreased activity of OPRM1 protein] which co-treated with Morphine] affects the localization of Guanosine 5'-O-(3-Thiotriphosphate)11413242
D009271NaltrexoneNaltrexone inhibits the reaction [CYM51010 promotes the reaction [[OPRD1 protein binds to OPRM1 protein] which binds to Guanosine 5'-O-(3-Thiotriphosphate)]]23818586
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of OPRM1 mRNA"25554681
D009538Nicotine[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Nicotine15778877
D026423S-Nitroso-N-Acetylpenicillamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]]"18652891
D026423S-Nitroso-N-AcetylpenicillamineS-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCA protein]18652891
D026423S-Nitroso-N-AcetylpenicillamineS-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]18652891|2123540
D026423S-Nitroso-N-AcetylpenicillamineS-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RAF1 protein]21235400
D026423S-Nitroso-N-AcetylpenicillamineS-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein]18652891
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [FK 409 promotes the reaction [OPRM1 protein binds to PRKCG protein]]"21235400
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [FK 409 promotes the reaction [OPRM1 protein binds to RAF1 protein]]"21235400
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]]"18652891
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]"18652891
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein binds to RAF1 protein]]"21235400
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to RAF1 protein]]"21235400
C025256nonylphenolnonylphenol results in increased expression of OPRM1 mRNA15620428
D009638Norepinephrine[dextrallorphan binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D009638Norepinephrine[Dextromethorphan binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D009638Norepinephrine[Dextropropoxyphene binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D009638Norepinephrine[Dextrorphan binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D009638Norepinephrine[Levallorphan binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D009638Norepinephrine[Levorphanol binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D009638Norepinephrine[Methadone binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D009638Norepinephrine[Methadyl Acetate binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D009638Norepinephrine[Tramadol binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
C440369N-propargylN-propargyl binds to OPRM1 protein11591513
D020866omega-Conotoxin GVIA"omega-Conotoxin GVIA inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein results in increased transport of Barium]]"12031848
D010098OxycodoneOxycodone binds to OPRM1 protein7562497
D010111Oxymorphone"Oxymorphone affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D010111OxymorphoneOxymorphone binds to and affects the activity of OPRM1 protein19800397
D010111Oxymorphone"Oxymorphone affects the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"19800397
D010111OxymorphoneOxymorphone binds to and results in increased activity of OPRM1 protein16343768|1759530
D010269ParaquatParaquat results in decreased expression of OPRM1 mRNA26498265
C580857paynantheinepaynantheine binds to OPRM1 protein27192616
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OPRM1 mRNA"25510870
D020881Enkephalin, D-Penicillamine (2,5)-"Enkephalin, D-Penicillamine (2,5)- binds to OPRM1 protein"7562497
D010423PentazocinePentazocine binds to and results in decreased activity of OPRM1 protein3744788
C049352phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide[phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Morphine17996026
C049352phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamidephenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide binds to and results in decreased activity of OPRM1 protein17996026|9396060
C049352phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide"phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide promotes the reaction [deltorphin II, Ala(2)- results in increased activity of [OPRD1 protein binds to OPRM1 protein]]"23818586
D010672Phenytoin[cyprodime binds to and results in decreased activity of OPRM1 protein] which results in decreased susceptibility to Phenytoin7870991
D010712Phosphatidic Acids[1-Butanol inhibits the reaction [PLD2 protein results in increased chemical synthesis of Phosphatidic Acids]] affects the reaction [PENK protein binds to and results in increased activity of OPRM1 protein]14720217
D010852PicrotoxinPicrotoxin results in increased expression of OPRM1 mRNA15170462
D010862PilocarpinePilocarpine results in decreased expression of OPRM1 protein17919468
D011188Potassium"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]]"12031848
D011188Potassium"Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [OPRM1 protein affects the reaction [Potassium results in increased transport of Barium]]"12031848
D011188PotassiumOPRM1 protein affects the reaction [Potassium results in increased abundance of Catecholamines]12031848
D011188PotassiumOPRM1 protein affects the reaction [Potassium results in increased transport of Barium]12031848
D011431DextropropoxypheneDextropropoxyphene binds to OPRM1 protein7562497
D011431Dextropropoxyphene[Dextropropoxyphene binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D011431Dextropropoxyphene[Dextropropoxyphene binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
C017947sodium arsenitesodium arsenite affects the methylation of OPRM1 gene28589171
C580856speciogyninespeciogynine binds to OPRM1 protein27192616
C580856speciogyninespeciogynine binds to OPRM1 protein27192616
D012460SulfasalazineSulfasalazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of OPRM1 mRNA]11901219
D012460SulfasalazineSulfasalazine inhibits the reaction [TNF protein results in increased expression of OPRM1 mRNA]11901219
C523979tapentadoltapentadol binds to and results in increased activity of OPRM1 protein17656655
C523979tapentadoltapentadol binds to OPRM1 protein17656655
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of OPRM1 mRNA19465110
D013755Tetradecanoylphorbol AcetateSulfasalazine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of OPRM1 mRNA]11901219
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate results in increased expression of OPRM1 mRNA11901219
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Calcium] inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate inhibits the reaction [Morphine promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of OPRM1 mRNA25613284
C050504tianeptinetianeptine binds to and results in increased activity of OPRM1 protein27192616
D014147TramadolTramadol binds to OPRM1 protein7562497
D014147Tramadol[Tramadol binds to OPRM1 protein] which results in decreased uptake of Norepinephrine7562497
D014147Tramadol[Tramadol binds to OPRM1 protein] which results in decreased uptake of Serotonin7562497
D014212Tretinoinmitragynine inhibits the reaction [Tretinoin results in increased expression of OPRM1 mRNA]23608241
D014212TretinoinMorphine inhibits the reaction [Tretinoin results in increased expression of OPRM1 mRNA]23608241
D014212TretinoinNaloxone inhibits the reaction [Morphine inhibits the reaction [Tretinoin results in increased expression of OPRM1 mRNA]]23608241
D014212TretinoinTretinoin results in increased expression of OPRM1 mRNA23608241
D014227TriazinesTriazines analog binds to OPRM1 protein12350293
C447082tricarbonyldichlororuthenium (II) dimertricarbonyldichlororuthenium (II) dimer affects the expression of OPRM123358127
C012589trichostatin Atrichostatin A affects the expression of OPRM1 mRNA17452465
C111212TRK 820TRK 820 binds to OPRM1 protein22742909
C111212TRK 820TRK 820 metabolite binds to OPRM1 protein22742909
C059393tyrosyl-arginyl-phenylalanyl-glycinamidetyrosyl-arginyl-phenylalanyl-glycinamide binds to and results in increased activity of OPRM1 protein21870874
C092721tyrosyl-tetrahydroisoquinolinecarbonyl-psi(methylamino)phenylalanyl-phenylalanine"tyrosyl-tetrahydroisoquinolinecarbonyl-psi(methylamino)phenylalanyl-phenylalanine inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- results in increased activity of [OPRD1 protein binds to OPRM1 protein]]"23818586
C045444U 69593U 69593 binds to OPRM1 protein7562497
D014635Valproic AcidValproic Acid results in decreased methylation of OPRM1 gene29154799
D014635Valproic AcidValproic Acid affects the expression of OPRM1 mRNA17452465
C107385valyl-prolyl-aspartyl-prolyl-argininevalyl-prolyl-aspartyl-prolyl-arginine inhibits the reaction [Morphine results in increased activity of OPRM1 protein]11272841
D001335Vehicle EmissionsVehicle Emissions affects the methylation of OPRM1 gene25560391
D014801Vitamin AVitamin A affects the expression of OPRM1 mRNA17289162
D014801Vitamin AVitamin A affects the expression of OPRM1 protein17289162
D015032Zinccalphostin C inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCA protein]]18652891
D015032Zinccalphostin C inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D015032Zinccalphostin complex inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein binds to RAF1 protein]]21235400
D015032Zinc"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]"18652891
D015032Zinc"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein binds to RAF1 protein]]"21235400
D015032Zinc"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to RAF1 protein]]"21235400
D015032ZincRGS17 protein affects the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D015032Zinc[Tetradecanoylphorbol Acetate co-treated with Calcium] inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D015032ZincTetradecanoylphorbol Acetate inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]18652891
D015032ZincZinc inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]21235400
D015032ZincZinc inhibits the reaction [Zinc promotes the reaction [OPRM1 protein binds to RAF1 protein]]21235400
D015032ZincZinc promotes the reaction [OPRM1 protein binds to MAPK1 protein]21235400
D015032ZincZinc promotes the reaction [OPRM1 protein binds to MAPK3 protein]21235400
D015032ZincZinc promotes the reaction [OPRM1 protein binds to PRKCA protein]18652891
D015032ZincZinc promotes the reaction [OPRM1 protein binds to PRKCB protein]18652891
D015032ZincZinc promotes the reaction [OPRM1 protein binds to PRKCG protein]18652891|2123540
D015032ZincZinc promotes the reaction [OPRM1 protein binds to PRKCG protein binds to RAF1 protein]21235400
D015032ZincZinc promotes the reaction [OPRM1 protein binds to RAF1 protein]21235400
D015032ZincZinc promotes the reaction [OPRM1 protein binds to RGS17 protein]18652891
D015032Zinc"Zinc inhibits the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]"2162496
D015032Zinc"Zinc inhibits the reaction [Magnesium promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]]"2162496
D015032Zinc"Zinc inhibits the reaction [Manganese promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein]]"2162496
D015054ZymosanZymosan results in increased expression of OPRM1 mRNA18977430
D015054Zymosan[Zymosan co-treated with Morphine] results in increased expression of OPRM1 mRNA15979727
D015054ZymosanZymosan results in increased expression of OPRM1 mRNA15979727

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0001965G-protein alpha-subunit binding-IBA21873635  
GO:0001965G-protein alpha-subunit binding-IDA20214800  
GO:0004930G-protein coupled receptor activity-IBA21873635  
GO:0004930G-protein coupled receptor activity-ISS-  
GO:0004979beta-endorphin receptor activity-IBA21873635  
GO:0004979beta-endorphin receptor activity-IMP9689128  
GO:0005245voltage-gated calcium channel activity-ISS-  
GO:0005515protein binding-IPI14573758  19788913  20214800  23597562  23840749  
GO:0008022protein C-terminus binding-IEA-  
GO:0019904protein domain specific binding-IEA-  
GO:0031005filamin binding-IEA-  
GO:0031681G-protein beta-subunit binding-IBA21873635  
GO:0038047morphine receptor activity-IBA21873635  
GO:0038047morphine receptor activity-ISS-  
GO:0042277peptide binding-IBA21873635  
GO:0042923neuropeptide binding-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0002438acute inflammatory response to antigenic stimulus-IEA-  
GO:0007186G-protein coupled receptor signaling pathway-TAS-  
GO:0007187G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger-IBA21873635  
GO:0007187G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger-TAS7905839  
GO:0007191adenylate cyclase-activating dopamine receptor signaling pathway-IEA-  
GO:0007194negative regulation of adenylate cyclase activity-ISS-  
GO:0007200phospholipase C-activating G-protein coupled receptor signaling pathway-ISS-  
GO:0007218neuropeptide signaling pathway-IBA21873635  
GO:0007218neuropeptide signaling pathway-IEA-  
GO:0007600sensory perception-NAS9689128  
GO:0007626locomotory behavior-IEA-  
GO:0008285negative regulation of cell proliferation-TAS2159143  
GO:0009314response to radiation-IEA-  
GO:0019221cytokine-mediated signaling pathway-TAS-  
GO:0019233sensory perception of pain-IBA21873635  
GO:0019233sensory perception of pain-ISS-  
GO:0031635adenylate cyclase-inhibiting opioid receptor signaling pathway-IEA-  
GO:0032094response to food-IEA-  
GO:0032100positive regulation of appetite-IEA-  
GO:0032496response to lipopolysaccharide-IEA-  
GO:0038003opioid receptor signaling pathway-IBA21873635  
GO:0038003opioid receptor signaling pathway-ISS-  
GO:0042060wound healing-IEA-  
GO:0042220response to cocaine-IEA-  
GO:0042755eating behavior-IEA-  
GO:0044849estrous cycle-IEA-  
GO:0048149behavioral response to ethanol-IMP21039637  
GO:0050769positive regulation of neurogenesis-ISS-  
GO:0051930regulation of sensory perception of pain-IEA-  
GO:0060079excitatory postsynaptic potential-IEA-  
GO:0061358negative regulation of Wnt protein secretion-IMP20214800  
GO:0070374positive regulation of ERK1 and ERK2 cascade-ISS-  
GO:0070588calcium ion transmembrane transport-IEA-  
GO:0070848response to growth factor-IEA-  
GO:0080135regulation of cellular response to stress-IMP21039637  
GO:0106072negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway-IEA-  
GO:2000310regulation of NMDA receptor activity-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005768endosome-ISS-  
GO:0005783endoplasmic reticulum-TAS9242668  
GO:0005794Golgi apparatus-TAS9242668  
GO:0005886plasma membrane-ISS-  
GO:0005886plasma membrane-TAS-  
GO:0005887integral component of plasma membrane-IBA21873635  
GO:0005887integral component of plasma membrane-TAS7905839  
GO:0005925focal adhesion-IEA-  
GO:0030424axon-ISS-  
GO:0030425dendrite-ISS-  
GO:0032590dendrite membrane-IEA-  
GO:0032839dendrite cytoplasm-IEA-  
GO:0042383sarcolemma-IEA-  
GO:0043005neuron projection-IBA21873635  
GO:0043204perikaryon-IEA-  
GO:0045121membrane raft-IEA-  
GO:0098794postsynapse-IEA-  
KEGG ID KEGG Term
hsa04080Neuroactive ligand-receptor interaction
Reactome ID Reactome Term Evidence
R-HSA-111885Opioid SignallingTAS
R-HSA-1280215Cytokine Signaling in Immune systemTAS
R-HSA-162582Signal TransductionTAS
R-HSA-168256Immune SystemTAS
R-HSA-202040G-protein activationTAS
R-HSA-372790Signaling by GPCRTAS
R-HSA-373076Class A/1 (Rhodopsin-like receptors)TAS
R-HSA-375276Peptide ligand-binding receptorsTAS
R-HSA-388396GPCR downstream signallingTAS
R-HSA-418594G alpha (i) signalling eventsTAS
R-HSA-449147Signaling by InterleukinsTAS
R-HSA-500792GPCR ligand bindingTAS
R-HSA-6785807Interleukin-4 and 13 signalingTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
25598501Regional brain [(11)C]carfentanil binding following tobacco smoking. (2015 Jun 3)Domino EFProg Neuropsychopharmacol Biol Psychiatry
23032071Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. (2013 Feb)Schacht JPNeuropsychopharmacology
23651028OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. (2013 May)Haerian BSPharmacogenomics
24729984Variation in Mu-Opioid Receptor Gene (OPRM1) as a Moderator of Naltrexone Treatment to Reduce Heavy Drinking in a High Functioning Cohort. (2013 Jan 1)Chen ACJ Alcohol Drug Depend
25556837Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity. (2015 Jun)Mouly SBr J Clin Pharmacol
15558714Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence. (2005 Feb 5)Smith RJAm J Med Genet B Neuropsychiatr Genet
24837580Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: an examination of Koob's allostatic model in humans. (2014 Jul 1)Bujarski SDrug Alcohol Depend
23318993Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. (2013 Jun)Manini AFJ Med Toxicol
29564682Opioid Exposure is Associated with Aberrant DNA Methylation of OPRM1 Promoter Region in a Chinese Han Population. (2018 Mar 21)Xu JBiochem Genet
26092968Influence of the A118G Polymorphism of the OPRM1 Gene and Exon 3 VNTR Polymorphism of the DRD4 Gene on Cigarette Craving After Alcohol Administration. (2016 May)Lechner WVNicotine Tob Res
26792136The AC/AG Diplotype for the 118A>G and IVS2 + 691G>C Polymorphisms of OPRM1 Gene is Associated with Sleep Quality Among Opioid-Dependent Patients on Methadone Maintenance Therapy. (2016 Jun)Zahari ZPain Ther
19860800Initial evidence of an association between OPRM1 and adolescent alcohol misuse. (2010 Jan)Miranda RAlcohol Clin Exp Res
18028530Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. (2008 Jan)Tidey JWAlcohol Clin Exp Res
22509402Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial. (2012)Marteau TMPLoS One
21143246Neurotransmitter and neuromodulator genes associated with a history of depressive symptoms in individuals with alcohol dependence. (2011 Mar)Kertes DAAlcohol Clin Exp Res
15525999Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. (2005 Feb)Bart GNeuropsychopharmacology
24086514Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. (2013)Beer BPLoS One
23405975Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians. (2013 Nov)Daher MPain Pract
21576462Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. (2011 May 31)Ray RProc Natl Acad Sci U S A
27594419Neural response to alcohol taste cues in youth: effects of the OPRM1 gene. (2017 Nov)Korucuoglu OAddict Biol
25823631The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. (2015 Jan)Bauer IEAm J Addict
26581429The Opposing Roles of IVS2+691 CC Genotype and AC/AG Diplotype of 118A>G and IVS2+691G>C of OPRM1 Polymorphisms in Cold Pain Tolerance Among Opioid-Dependent Malay Males on Methadone Therapy. (2015 Dec)Zahari ZPain Ther
29123234Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. (2017 Dec)Schacht JPNeuropsychopharmacology
21410481The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype. (2011 Jun)Setiawan EAlcohol Clin Exp Res
12116270Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample. (2002 Jun 1)Xu KAm J Med Genet
27095017Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms. (2016 Aug 1)Nuechterlein EBProg Neuropsychopharmacol Biol Psychiatry
20077761Gender differences in the genetic risk for alcohol dependence--the results of a pharmacogenetic study in Korean alcoholics. (2009 Dec)Kim SGNihon Arukoru Yakubutsu Igakkai Zasshi
29333880Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate. (2018)Crist RCAm J Drug Alcohol Abuse
18537939Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. (2008 Jul)Arias AJAlcohol Clin Exp Res
24892317Genetic variants associated with addictive behavior in Colombian addicted and non-addicted to heroin or cocaine. (2013 Jan)Isaza CColomb Med (Cali)
22046326'Smoking genes': a genetic association study. (2011)Verde ZPLoS One
29431852Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. (2018 Apr)Anton RFAlcohol Clin Exp Res
22676196A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation. (2012 Jun)Verhagen MPharmacogenomics
12960749A genetic association study of the mu opioid receptor and severe opioid dependence. (2003 Sep)Crowley JJPsychiatr Genet
27447243Association study of DRD2 A2/A1, DRD3 Ser9Gly, DbetaH -1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence. (2016 Sep 1)Ragia GDrug Metab Pers Ther
24724887Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans. (2014 May-Jun)Arias AJAm J Addict
22309038Possible association between OPRM1 genetic variance at the 118 locus and alcohol dependence in a large treatment sample: relationship to alcohol dependence symptoms. (2012 Jul)Koller GAlcohol Clin Exp Res
21900886Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. (2012 Jan)Ray LANeuropsychopharmacology
23876228Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. (2014 Jan)Ray LAAlcohol Clin Exp Res
18690118Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. (2008 Sep)Perkins KABehav Pharmacol
18250251An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. (2008 Feb)Anton RFArch Gen Psychiatry
27370058[mu-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample]. (2016 Summer)Gurel SCTurk Psikiyatri Derg
18499348Nicotine abstinence-induced cerebral blood flow changes by genotype. (2008 Jun 27)Wang ZNeurosci Lett
28115739Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. (2017 Mar)Smith AHMol Psychiatry
11424981Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. (2001 Jan 8)Franke PAm J Med Genet
22028400Cigarette experimentation in Mexican origin youth: psychosocial and genetic determinants. (2012 Jan)Wilkinson AVCancer Epidemiol Biomarkers Prev
24273683Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note. (2013 Apr 23)Blum KJ Addict Res Ther
24035285Opioid system genes in alcoholism: a case-control study in Croatian population. (2013 Oct)Cupic BNeuropeptides
17374034Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. (2007 Apr)Gelernter JAlcohol Clin Exp Res
29391279Gut microbiota modulates alcohol withdrawal-induced anxiety in mice. (2018 May 1)Xiao HWToxicol Lett
26449981Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4, and OPRM1 genotypes. (2015 Oct 8)Kleinjan MBMC Pulm Med
29497164The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption. (2018 Jun)Sloan MENeuropsychopharmacology
25161819Genetic, psychosocial, and demographic factors associated with social disinhibition in Mexican-origin youth. (2014 Jul)Archer NPBrain Behav
21946895OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence. (2011 Dec)Coller JKPharmacogenet Genomics
23226066Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent. (2012)Al-Eitan LNPharmgenomics Pers Med
24447405Association between common genetic variants in the opioid pathway and smoking behaviors in Chinese men. (2014 Jan 21)Fang JBehav Brain Funct
22909206Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone. (2012 Jul)Setiawan EPharmacogenomics
15048644Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics. (2004 Apr 1)Sullivan PFAm J Med Genet B Neuropsychiatr Genet
24167729Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs. (2013)Xu YPain Res Treat
25442002A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice. (2015 May 15)Bilbao ABiol Psychiatry
22744787A118G mu opioid receptor polymorphism among drug addicts in Malaysia. (2012 Mar)Nagaya DJ Integr Neurosci
17768272Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. (2007 Sep)Ray LAArch Gen Psychiatry
15252283Association of functional opioid receptor genotypes with alcohol dependence in Koreans. (2004 Jul)Kim SGAlcohol Clin Exp Res
24945054- (2014 May)Jonas DE-
22990223Lack of association of OPRM1 genotype and smoking cessation. (2013 Mar)Munafo MRNicotine Tob Res
28548579Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder. (Spring 2017)Hirasawa-Fujita MClin Schizophr Relat Psychoses
25772090Catechol-O-methyltransferase (COMT) gene polymorphisms are associated with baseline disability but not long-term treatment outcome in patients with chronic low back pain. (2015 Nov)Omair AEur Spine J
11092766Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. (2000 Nov 22)Hoehe MRHum Mol Genet
17224915Association of the mu-opioid receptor gene with smoking cessation. (2007 Oct)Munafo MRPharmacogenomics J
22978509Convergence of genome-wide association and candidate gene studies for alcoholism. (2012 Dec)Olfson EAlcohol Clin Exp Res
23543091The mu-opioid receptor and treatment response to naltrexone. (2013 Jul-Aug)Thorsell AAlcohol Alcohol
19393386[Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form]. (2009 Apr)Desjardins SEncephale
27510425Low mu-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis. (2017 Feb)Hermann DNeuropsychopharmacology
22260295Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex. (2013 Nov)Kleinjan MAddict Biol
15902904Association of polymorphisms in nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4), mu-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients. (2004 Oct-Nov)Kim SAAlcohol
24884878Subjective health complaints in patients with lumbar radicular pain and disc herniation are associated with a sex - OPRM1 A118G polymorphism interaction: a prospective 1-year observational study. (2014 May 18)Hasvik EBMC Musculoskelet Disord
27459726A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology. (2016 Jul 26)Bernardi RETransl Psychiatry
23223006OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study. (2013 Feb)Chen YTJ Hum Genet
17978999Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. (2007 Nov)Ray RNicotine Tob Res
24479196Optimization and characterization of an opioid kappa receptor (OPRK1) antagonist (2010)Guerrero M-
17503481The opioid system in alcohol and drug dependence: family-based association study. (2007 Oct 5)Xuei XAm J Med Genet B Neuropsychiatr Genet
23240858Fronto-striatal functional connectivity during response inhibition in alcohol dependence. (2013 May)Courtney KEAddict Biol
18482155Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial. (2008 Jul)O'Malley SSAlcohol Clin Exp Res
25937240Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects. (2015 Aug)Bach PEur Neuropsychopharmacol
24446757Initial responses to the first dose of nicotine in novel smokers: the role of exposure to environmental smoking and genetic predisposition. (2014)Schuck KPsychol Health
20479755A genetic determinant of the striatal dopamine response to alcohol in men. (2011 Aug)Ramchandani VAMol Psychiatry
19523047Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. (2009 Jul)Ooteman WAddict Biol
21193270Genetic moderators and psychiatric mediators of the link between sexual abuse and alcohol dependence. (2011 Jun 1)Copeland WEDrug Alcohol Depend
24956254Pharmacogenomics of methadone maintenance treatment. (2014 May)Somogyi AAPharmacogenomics
25655461Clinically relevant genetic biomarkers from the brain in alcoholism with representation on high resolution chromosome ideograms. (2015 Apr 15)Manzardo AMGene
12648891Introducing a new recruitment approach to sample collection for genetic association studies in opioid dependence. (2003 Feb)Franke PEur Psychiatry
20153935A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys. (2010 Jun 1)Vallender EJDrug Alcohol Depend
25122903A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the mu opioid receptor gene OPRM1 via hnRNPH interactions. (2014 Aug 13)Xu JJ Neurosci
26288297[Stabilization of remission in patients with opioid dependence with naltrexone implant: a pharmacogenetic approach]. (2015)Krupitsky capital IE, Cyrilliccapital EM, CyrillicZh Nevrol Psikhiatr Im S S Korsakova
22914673Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. (2012 Oct)Zhang HJ Hum Genet
26692286Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms. (2016 Jan)Jones JDAm J Addict
22515274Association of micro-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. (2012 May)Chamorro AJAddict Biol
22781865Testing multiple levels of influence in the intergenerational transmission of alcohol disorders from a developmental perspective: the example of alcohol use promoting peers and mu-opioid receptor M1 variation. (2012 Aug)Chassin LDev Psychopathol
21895723The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. (2012 Mar)Ray LAAlcohol Clin Exp Res
24661324Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. (2014 Aug)Garbutt JCAddiction
25410894Genetic polymorphisms and response to medications for alcohol use disorders: a systematic review and meta-analysis. (2014 Sep)Jonas DEPharmacogenomics
28471875Genetic predictors of recovery in low back and lumbar radicular pain. (2017 Aug)Bjorland SPain
23254216Involvement of the mu-opioid receptor gene polymorphism A118G in the efficacy of detoxification of alcohol dependent patients. (2013 Mar)Marini VAddict Behav
27958381A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence. (2018 Jan)Crist RCPharmacogenomics J
16476706Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. (2006 Mar 15)Zhang HHum Mol Genet
29577422NOTCH4 is a possible novel susceptibility gene for dilated cardiomyopathy in the Chinese population: A case-control study. (2018 Mar 26)Shi XJ Clin Lab Anal
15584875Alcoholism: genes and mechanisms. (2004 Dec)Oroszi GPharmacogenomics
24220019Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism. (2014 Aug)Enoch MAPharmacol Biochem Behav
24411804Subjective responses to alcohol in the lab predict neural responses to alcohol cues. (2014 Jan)Courtney KEJ Stud Alcohol Drugs
18181266A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin. (2007 Dec)Kapur SJ Integr Neurosci
22882391Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. (2012 Sep-Oct)Smelson DAm J Addict
25941919Gene-gene interaction of mu-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect. (2015 Jun)Misailidis GDrug Metab Pers Ther
20201854Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. (2010 Feb)Yuferov VAnn N Y Acad Sci
10982041Variant detection at the delta opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence. (2000 Jul)Gelernter JHum Genet
17979515Polymorphisms in the mu-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humans. (2007 Oct)van der Zwaluw CSPharmacogenomics
22397905Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects. (2013 Feb)Weerts EMInt J Neuropsychopharmacol
27046326A prospective study of genetic factors, human laboratory phenotypes, and heavy drinking in late adolescence. (2017 Sep)Hendershot CSAddict Biol
29385578Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial. (2018 Jan 29)Wright AJTransl Behav Med
16223057COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms. (2005 Jul)Goldman DJ Stud Alcohol Suppl
23240711Subjective response to alcohol among alcohol-dependent individuals: effects of the mu-opioid receptor (OPRM1) gene and alcoholism severity. (2013 Jan)Ray LAAlcohol Clin Exp Res
21957825Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. (2011 Jul-Aug)Chorbov VMJ Opioid Manag
24533225Analyzing Interaction of mu-, delta- and kappa-opioid Receptor Gene Variants on Alcohol or Drug Dependence Using a Pattern Discovery-based Method. (2013 May 14)Li ZJ Addict Res Ther
12815747Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. (2003 Jul 1)Luo XAm J Med Genet B Neuropsychiatr Genet
9756053Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1). (1998 Sep)Kranzler HRAlcohol Clin Exp Res
22071118Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians. (2012 Jun 1)Chen DDrug Alcohol Depend
23226031Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. (2009)Coller JKPharmgenomics Pers Med
28867064Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers. (2017 Nov)McLaughlin PJ Pediatr
22954510Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012 Dec)Ashenhurst JRPharmacol Biochem Behav
26125586The effect of alcohol priming on neural markers of alcohol cue-reactivity. (2015)Courtney KEAm J Drug Alcohol Abuse
25545355Genetic variants and early cigarette smoking and nicotine dependence phenotypes in adolescents. (2014)O'Loughlin JPLoS One
9399694Mu opioid receptor gene variants: lack of association with alcohol dependence. (1997 Oct-Nov)Bergen AWMol Psychiatry
24421289Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. (2014 May-Jun)Ray LAAlcohol Alcohol
17207095A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. (2007 Jan)van den Wildenberg EAlcohol Clin Exp Res
23739600[Pharmacogenetics and the treatment of addiction]. (2013)Schellekens ANed Tijdschr Geneeskd
28300812[A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine]. (2016)Kibitov capital A, Cyrilliccapital O, CyrillicZh Nevrol Psikhiatr Im S S Korsakova
16899031Genetic moderators of naltrexone's effects on alcohol cue reactivity. (2006 Aug)McGeary JEAlcohol Clin Exp Res
21062464Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence. (2010 Nov 9)Marteau TMBMC Public Health
28409564Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. (2017 Dec)Schacht JPNeuropsychopharmacology
24527678Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex. (2014 Jun)Echeverry-Alzate VBr J Pharmacol
22516252Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism. (2012 Aug 7)Domino EFProg Neuropsychopharmacol Biol Psychiatry
19959688Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. (2009 Dec)Hardin JCancer Epidemiol Biomarkers Prev
23729673mu-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption. (2013 Sep-Oct)Rouvinen-Lagerstrom NAlcohol Alcohol
23177301[Genetic polymorphisms as tool indicators for individual vulnerability to smoking behaviour]. (2013 Jan 19)Barrot CMed Clin (Barc)
29137427Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence. (2017 Oct 13)Kong XOncotarget
21463027The mu-opioid receptor and the evolution of mother-infant attachment: theoretical comment on Higham et al. (2011). (2011 Apr)Curley JPBehav Neurosci
20482509Pharmacogenetics of alcohol and alcohol dependence treatment. (2010)Kranzler HRCurr Pharm Des
18433502Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians. (2008 Apr 23)Ehlers CLBMC Med Genet
26392368Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. (2016 Mar)Schwantes-An THBehav Genet
19764934The interaction of reward genes with environmental factors in contribution to alcoholism in mexican americans. (2009 Dec)Du YAlcohol Clin Exp Res
16451620A simple nonparametric multipoint procedure to test for linkage through mothers or fathers as well as imprinting effects in the presence of linkage. (2005 Dec 30)Lemire MBMC Genet
22429255Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. (2012 Jun)Bujarski SExp Clin Psychopharmacol
16887046The mu-opioid receptor gene and smoking initiation and nicotine dependence. (2006 Aug 4)Zhang LBehav Brain Funct
20560679Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes. (2010 Jun 1)Fonseca FMol Diagn Ther
25418439The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. (2014 Nov 21)Bauer IEAm J Addict
17416470Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. (2007 Oct 8)Glatt SJDrug Alcohol Depend
29781244OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients. (2018 May 20)Muriel JAnn N Y Acad Sci
28805974Effect of single-nucleotide polymorphisms in ADH1B, ADH4, ADH1C, OPRM1, DRD2, BDNF, and ALDH2 genes on alcohol dependence in a Caucasian population. (2017 Aug)Katsarou MSPharmacol Res Perspect
25760804Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial. (2015 May)Oslin DWJAMA Psychiatry
25715171OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients. (2015 May)Foulds JAPharmacogenet Genomics
16679777Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. (2006)Nishizawa DNeuropsychobiology
25266401Prenatal exposure to cigarette smoke interacts with OPRM1 to modulate dietary preference for fat. (2015 Jan)Lee KWJ Psychiatry Neurosci
28780411Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms. (2018 Apr)Henderson-Redmond ANBrain Res Bull
22551036Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. (2012 Nov)Anton RFAlcohol Clin Exp Res
21039637Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. (2011 Jan)Ray LAAlcohol Clin Exp Res